Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The VETERANS AFFAIRS, DEPARTMENT OF has issued a Tender notice for the procurement of a Long Term Specialized Reference Laboratory for Measurable Residual Disease Mrd Detection in Hematologic Malignancies Base Plus 4 912683131 in the USA. This Tender notice was published on 03 Jul 2026 and is scheduled to close on 10 Jul 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 144483819, while the tender notice number is 36C26026Q0807 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Long Term Specialized Reference Laboratory for Measurable Residual Disease Mrd Detection in Hematologic Malignancies Base Plus 4 912683131
Deadline: 10 Jul 2026
Posting Date: 03 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144483819
Document Ref. No.: 36C26026Q0807
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
STATEMENT OF WORK (SOW) for Reference Laboratory Services for specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies
BACKGROUND
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL).
The contractor shall provide MRD testing of an FDA-cleared, next generation sequencing (NGS)-based assay for blood and bone marrow samples from patients diagnosed with multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and B-cell acute lymphoblastic leukemia (B-ALL).
Testing shall be performed at the contractor s CLIA-certified (requirement) and CAP-accredited (or equivalent; requirement) reference laboratory and include full interpretation and reporting of results to VHAPORHCS clinicians.
This full-service Reference Laboratory contract will provide services required for specimen testing, interpretation, testing supplies, and customer service. This requirement will ensure accurate and timely test results are made available to healthcare providers which will ensure high quality healthcare is provided to the Veterans at the VA Portland Health Care System.
SCOPE
The objective of this agreement is to provide VHAPORHCS with access to FDA-cleared and clinically validated MRD testing to support direct patient care within the Hematology/Oncology and Pathology and Laboratory Medicine Services (PALMS), ensuring accurate disease monitoring and outcome assessment for veterans undergoing cancer therapy.
The contractor shall:
Provide MRD testing for the following specimen and disease types:
Bone marrow aspirate...
Notice ID: 36c26026q0807
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 260-network contract office 20 (36c260)
Product Service Code: q301 - reference laboratory testing
NAICS Code: 621511 - Medical Laboratories
Inactive Dates: jul 25, 2026
Inactive Policy: manual
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google